91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
This news article, published on Clinical Trials Arena, outlines as well as help to launch new medicines.
-
This news article, first published on Applied Clinical Trials, outlines that that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective.
-
91黑料 and LEO Pharma join forces on clinical trial mission
This news article, published on PharmaTimes online, indicates how the collaboration will concentrate on launching and running studies within medical dermatology.
-
This news article, first published on Contract Pharma, covers the .
-
Laura Iliescu explores the , particularly how PAOs can inform trial design and the creation of patient registries.
-
If the last few years have taught us anything, it’s that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together in a truly collaborative way. The opportunity for the clinical development industry is to take what we have learned about how we can work together and use this to continue to drive progress. To strategically support clients, at 91黑料, this means partnering with sponsors in a way that goes beyond a traditional CRO. It means being a trusted partner.
In this Jeff James, EVP Alliance Management, offers his perspective on what it takes to be a trusted partner to sponsors in the clinical development industry. -
Samir Shah, President, Strategic Solutions at 91黑料 contributes to this Applied Clinical Trials article discussing the in the CRO industry.
Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication of MultiMedia Healthcare, LLC. All rights reserved.
-
How this top CEO helped Pfizer turbocharge the covid-19 vaccine
Steve Cutler discusses 91黑料's covid-19 efforts, the importance of building a good team, and more in this interview with Investor's Business Daily.
-
Louisa Roberts, VP of Corporate Development and Partnerships, considers .
-
considers how partnering with a CRO can help emerging biotechs to secure funding.
